American Healthcare REIT Inc
9 nominees · 3 ballot items.
Elect nine directors; ratify Deloitte & Touche LLP as independent registered public accounting firm for 2026; and approve, on an advisory (non-binding) basis, the compensation paid to the company’s named executive officers for 2025.
Follow how the vote landed and what changed on American Healthcare REIT Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORVote to elect nine incumbent directors (Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff, Scott A. Estes, Brian J. Flornes, Dianne Hurley, Marvin R. O’Quinn, Valerie Richardson and Wilbur H. Smith III) each to serve a one-year term expiring at the 2027 Annual Meeting of Stockholders.
- 2
Ratification of Appointment of Independent Registered Public Accounting Firm
ManagementBoard: FORVote to ratify the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
- 3
Advisory Vote to Approve Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding, advisory vote to approve the compensation paid to the Company’s named executive officers for the year ended December 31, 2025, as disclosed in the Proxy Statement.
More detail
This non-binding advisory proposal asks stockholders to endorse the total compensation awarded to the named executive officers for 2025 as disclosed in the proxy. Management seeks approval to validate its compensation framework which emphasizes a mix of base salary, short-term cash incentives tied to Normalized FFO and Same-Store NOI metrics, and long-term equity awards (50% performance-based RSUs tied to relative TSR and 50% time-based RSUs) to align executives’ interests with stockholders. The Compensation Committee highlights use of an independent compensation consultant, significant at-risk/ performance-based pay (over three-quarters of target pay for most NEOs), and multi-year vesting to support retention and alignment. The advisor vote is non-binding, but the Board states it will consider stockholder feedback in future pay decisions, making this vote a key governance signal. Supporters would argue the program is rigorous—using objective corporate metrics (Normalized FFO per share and Same-Store NOI growth) and relative TSR for multi-year awards—while providing downside protection and clawback policies. Opponents might object that a substantial portion of pay is equity whose ultimate payout depends on market conditions and peer selection, or that certain discretion remains in annual bonuses. Company-specific context includes strong 2025 performance (Normalized FFO growth, Same-Store NOI growth, and significant equity raises) that management links to pay outcomes and higher bonus payouts. The Board’s recommendation for a FOR vote is premised on this alignment with strategic performance, the governance processes described (independent Compensation Committee, consultant engagement, clawback policy), and the Committee’s view that stockholder endorsement will support retention and incentive continuity. Given the advisory nature, the principal practical effect is reputational and informative for future compensation design rather than binding legal change.
Nominees on the ballot9
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.4% | 16,124,024 | $760M |
| 2 | BlackRock, Inc. | 7.8% | 15,089,850 | $712M |
| 3 | STATE STREET CORP | 5.0% | 9,545,044 | $452M |
| 4 | BlackRock, Inc. | 4.4% | 8,420,335 | $397M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 8,198,624 | $387M |
| 6 | PRINCIPAL FINANCIAL GROUP INC | 3.8% | 7,292,014 | $344M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.8% | 5,357,607 | $266M |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 2.5% | 4,821,336 | $227M |
| 9 | FMR LLC | 2.5% | 4,807,238 | $227M |
| 10 | Invesco Ltd. | 2.1% | 4,095,596 | $193M |
Other Real Estate sector meetings6
Upcoming shareholder meetings at American Healthcare REIT Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the American Healthcare REIT Inc 2026 annual meeting?
- American Healthcare REIT Inc (AHR) holds its 2026 annual shareholder meeting on Wednesday, June 24, 2026.
- What is the record date for the American Healthcare REIT Inc 2026 meeting?
- The record date for the American Healthcare REIT Inc 2026 meeting is Wednesday, April 1, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for American Healthcare REIT Inc's 2026 meeting?
- The board is presenting 9 director nominees at the American Healthcare REIT Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the American Healthcare REIT Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the American Healthcare REIT Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.